 GUILFORD, Conn.--BUSINESS WIRE-- Covid19--DetectTM, Inc., a Connecticut-based health technology company, announced today that the National Institutes of Health NIH has selected the DetectTM Covid-19 Test to receive funding from the highly competitive Rapid Acceleration of Diagnostics Initiative RADxSM. The 8.1 million contract will facilitate the development and scale up manufacturing of Detects PCR-quality rapid at-home Covid-19 test to meet national testing demand. The Detect Covid-19 Test, curre 